AnneEdenEvinsMD

Clinical Trials

• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke Start of enrollment: 1998 Aug 01

  Completed

  Phase 4

• Smoking Relapse Prevention in Schizophrenia Start of enrollment: 2006 Apr 01

  Completed

  Phase 4

• Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia Start of enrollment: 2001 Jul 01

  Completed

  Phase 4

• Galantamine for Cognition in People With Schizophrenia Start of enrollment: 2004 Jan 01

  Completed

  Phase 4

• The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia Start of enrollment: 2005 Apr 01

  Completed

  Phase 4

• The Effects of Nicotine on Cognition in Schizophrenia Start of enrollment: 2004 Apr 01

  Completed

  Phase 4

• Study of the Effects of Mecamylamine and Varenicline in Schizophrenia Start of enrollment: 2007 Mar 01

  Completed

  Not Applicable

• A Comparison of Two Cognitive Batteries in People With Schizophrenia Start of enrollment: 2007 Dec 01

  Completed

  Not Applicable

• A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia Start of enrollment: 2007 Aug 01

  Completed

  Not Applicable

• Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia Start of enrollment: 2007 Dec 01

  Terminated

  Phase 1

• A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder Start of enrollment: 2008 Feb 01

  Completed

  Phase 4

• Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence Start of enrollment: 2008 Apr 01

  Completed

  Phase 3

• Cognitive Remediation With D-Cycloserine Start of enrollment: 2011 May 01

  Completed

  Phase 3

• A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence Start of enrollment: 2011 Dec 01

  Terminated

  Phase 2

• Join now to see all